Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Junxian Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2087-5467; OpenAlex author ID A5101702366. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Mature tertiary lymphoid structures tumor microenvironment-based risk model to assess patients with pancreatic ductal adenocarcinoma. Last author DOI 10.21037/tcr-2025-1601↗
  2. Erratum: Traditional Chinese Medicine Astragalus Polysaccharide Enhanced Antitumor Effects of the Angiogenesis Inhibitor Apatinib in Pancreatic Cancer Cells on… Co-author DOI 10.2147/ott.s355695↗
  3. Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on prolifer… Co-author DOI 10.2147/ott.s157129↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiang Su · 3 shared papers, 2018–2026 · strength 0.65
  2. Zheng Gu · 1 shared paper, 2026 · strength 0.39
  3. Bangwei Cao · 2 shared papers, 2018–2022 · strength 0.26
  4. Jing Wang · 1 shared paper, 2022 · strength 0.17
  5. Jun Wu · 1 shared paper, 2022 · strength 0.17
  6. Jun Wu · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.